AI-Driven Ketoreductase Engineering for Pharmaceutical Manufacturing and Industrial Biocatalysis

AI-Driven Ketoreductase Optimization for Industrial Biocatalysis

Ketoreductases (KREDs) are NADH- or NADPH-dependent oxidoreductases that catalyze the stereoselective reduction of ketones into chiral alcohols. These enzymes are widely used in pharmaceutical manufacturing, fine chemicals, agrochemicals, flavors and fragrances, and sustainable chemical synthesis.

Industrial processes require ketoreductases that combine high catalytic activity, excellent stereoselectivity, broad substrate compatibility, and reliable performance under manufacturing conditions.

Neoncorte Bio applies AI-driven protein engineering to optimize ketoreductases for improved catalytic efficiency, selectivity, stability, and scalable industrial production.

Why Optimize Ketoreductases?

Native ketoreductases often do not provide the complete set of properties required for commercial manufacturing.
Protein engineering enables targeted optimization to improve reaction performance while reducing process complexity and increasing manufacturing efficiency.
Optimization strategies are tailored according to substrate chemistry, reaction conditions, cofactor preferences, and production requirements.

Common Engineering Challenges

Organizations developing ketoreductases frequently seek improvements in:
  • Catalytic efficiency
  • Enantioselectivity
  • Diastereoselectivity
  • Substrate specificity
  • Expanded substrate scope
  • Cofactor specificity (NADH/NADPH)
  • Cofactor utilization efficiency
  • Thermostability
  • Solvent tolerance
  • pH stability
  • Product tolerance
  • Recombinant expression
  • Manufacturing scalability
Many industrial projects require simultaneous optimization of multiple enzyme properties.

Application Areas

AI-Driven Ketoreductase Optimization for Industrial Biocatalysis
  • Pharmaceutical Manufacturing

    Engineer ketoreductases for stereoselective synthesis of pharmaceutical intermediates and active pharmaceutical ingredient (API) precursors.
    Benefit: Improved process efficiency and access to high-purity chiral alcohols.
  • Fine Chemical Production

    Optimize KREDs for asymmetric reduction of ketones used in specialty chemicals.
    Benefit: Greater reaction selectivity and sustainable manufacturing.
  • Flavor and Fragrance Manufacturing

    Engineer KREDs for selective production of high-value aroma compounds.
    Benefit: High stereochemical purity and consistent product quality.
  • Green Chemistry

    Replace traditional chemical reduction methods with highly selective enzymatic catalysis.
    Benefit: Reduced waste generation and operation under mild reaction conditions.
  • Agrochemical Synthesis

    Develop ketoreductases with broader substrate compatibility for agrochemical intermediates.
    Benefit: Increased process flexibility and improved catalyst performance.
AI-Driven Ketoreductase Optimization for Industrial Biocatalysis

AI-Guided Ketoreductase Optimization

Neoncorte Bio combines computational protein engineering, structural biology, and machine learning to accelerate ketoreductase optimization.
Our engineering workflow may incorporate:
  • Protein sequence analysis
  • Structure-informed enzyme modeling
  • Active-site analysis
  • Cofactor-binding pocket optimization
  • Protein language models
  • Machine learning
  • Computational mutagenesis
  • Virtual mutational scanning
  • Fitness landscape prediction
  • Multi-objective optimization
  • Design-Build-Test-Learn (DBTL) methodologies
AI-guided workflows help prioritize promising variants for laboratory validation according to project-specific objectives.

Engineering Objectives

Depending on the target application, ketoreductases may be optimized for:
  • Higher catalytic activity
  • Improved catalytic efficiency
  • Enhanced enantioselectivity
  • Improved diastereoselectivity
  • Expanded substrate scope
  • Better activity toward sterically demanding substrates
  • Optimized NADH or NADPH utilization
  • Increased thermostability
  • Improved solvent tolerance
  • Greater operational stability
  • Higher recombinant expression
  • Reduced aggregation
  • Improved manufacturability
Multi-parameter optimization helps balance catalytic performance with industrial production requirements.
AI-Driven Ketoreductase Engineering for Pharma and Industrial Biocatalysis

Design-Build-Test-Learn (DBTL) Integration

Ketoreductase optimization benefits from iterative computational prediction and laboratory validation.
Neoncorte Bio supports:
  1. Protein sequence and structural analysis
  2. AI-guided mutation prioritization
  3. Variant design
  4. Experimental characterization
  5. Machine learning model refinement
  6. Successive Design-Build-Test-Learn (DBTL) cycles
This iterative workflow accelerates enzyme optimization while reducing unnecessary laboratory screening

What Neoncorte Bio Delivers

  • AI-guided ketoreductase optimization
  • Computational enzyme engineering
  • Structure-informed protein design
  • Multi-parameter optimization
  • Cofactor specificity engineering
  • Mutation prioritization
  • Computational mutagenesis
  • Design-Build-Test-Learn (DBTL) workflows
  • Confidential B2B enzyme engineering partnerships

Who We Work With

  • Pharmaceutical companies
  • CDMOs
  • Fine chemical manufacturers
  • Agrochemical companies
  • Industrial enzyme manufacturers
  • Biotechnology startups
  • Synthetic biology companies
  • Academic research organizations

Frequently Asked Questions (FAQs)

Neoncorte Bio

Where AI Meets Biotechnology
Neoncorte Bio is at the forefront of the convergence between artificial intelligence and enzyme engineering. Our team comprises experts in computational biology, bioinformatics, and machine learning, all driven by a mission to accelerate innovation in enzyme design. By leveraging our advanced AI models, we provide unparalleled solutions that enhance efficiency, reduce costs, and push the boundaries of what's possible in enzyme engineering
Proud Member of Leading Global AI Programs
Neoncorte Bio is part of the NVIDIA Inception and Nebius for Startups programs — two of the world’s leading ecosystems for high-performance AI innovation. These partnerships strengthen our ability to deliver next-generation AI-driven protein, enzyme, and aptamer engineering.
  • NVIDIA Inception Neoncorte Bio AI life sciences company
    As a member of NVIDIA Inception, Neoncorte Bio gains access to cutting-edge GPU technologies, expert guidance, and a global AI ecosystem that supports companies from prototype to production. The program empowers us to explore new AI opportunities and build high-performance biological design pipelines powered by NVIDIA’s world-class platform.
  • Nebius AI life sciences Neoncorte Bio
    Through Nebius for Startups, we gain access to high-performance compute infrastructure optimized for large-scale AI workloads, along with hands-on technical guidance and a strong community of innovative AI companies. Nebius enables us to train and deploy complex biological models more efficiently — accelerating enzyme, protein, and aptamer design while supporting rapid scaling of our R&D pipelines.
Publications
Scientific Publication of Neoncorte Bio Team
  • Modification of natural enzymes to introduce new properties and enhance existing ones is a central challenge in bioengineering. This study is focused on the development of Taq polymerase mutants that show enhanced reverse transcriptase (RTase) activity while retaining other desirable properties such as fidelity, 5′-3′ exonuclease activity, effective deoxyuracil incorporation, and tolerance to locked nucleic acid (LNA)-containing substrates.
  • The transcriptomic data are being frequently used in the research of biomarker genes of different diseases and biological states. The most common tasks there are the data harmonization and treatment outcome prediction. Both of them can be addressed via the style transfer approach. Either technical factors or any biological details about the samples which we would like to control (gender, biological state, treatment, etc.) can be used as style components.
  • List of all Neoncorte Bio publications dedicated to Molecular Biology, Biotechnology, Artificial Intelligence and Artificial Neural Networks, published mostly by Nikolay Russkikh, CEO of Neoncorte Bio

Our Expertise in Action
With extensive experience in AI applications and software engineering tailored to the life sciences, we specialize in solving complex challenges and delivering innovative solutions for our customers. Our work demonstrates a deep understanding of cutting-edge technologies and their application in the real world.
Here are examples of the types of projects we have successfully delivered:
  • Automated NGS Data Analysis:
    Designed a production-grade solution for the automated processing, annotation, and analysis of Next-Generation Sequencing (NGS) data.
  • Single-Cell Data Integration:
    Built state-of-the-art tools for integrating multimodal single-cell data, achieving recognition for technical excellence.
  • Metagenomic Classification Algorithms:
    Developed advanced methods for classifying sequencing reads in metagenomics research.
  • High-Throughput Image Processing Pipelines:
    Engineered an efficient pipeline to process millions of sequencing images with exceptional accuracy.
  • Cell Counting via AI:
    Created a computer vision solution for precise cell counting in microphotography images, streamlining data analysis.
Get in touch with our team
Phone: +1-503-754-3958
Email: contact@neoncorte.com